Brazil prosecutors probe price, intermediary on Bharat Covid-19 vaccine deal

Prosecutors questioned why the Health Ministry had agreed to buy the Bharat vaccine, which had not cleared regulatory hurdles, for around US$15 per dose: significantly more than what it paid for Pfizer's vaccine, which had regulatory approval.

RIO DE JANEIRO, BRAZIL - Brazilian federal prosecutors have opened an investigation into a contract worth R$1.6 billion (US$320 million) for 20 million doses of a Covid-19 vaccine made by India's Bharat Biotech, according to a document seen by Reuters on Tuesday, June 22.

The prosecutor-general's office (PGR) cited comparatively high prices, speedy talks and pending regulatory approvals as red flags for the Bharat contract signed in February, before similar deals with Pfizer Inc and Johnson & Johnson.

Bharat did not immediately respond to a request for comment outside of business hours in India . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?